SciVision Biotech Inc
TWSE:1786

Watchlist Manager
SciVision Biotech Inc Logo
SciVision Biotech Inc
TWSE:1786
Watchlist
Price: 90.4 TWD -1.74% Market Closed
Market Cap: 6.4B TWD
Have any thoughts about
SciVision Biotech Inc?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
SciVision Biotech Inc

Revenue
831.4m TWD
Cost of Revenue
-209.7m TWD
Gross Profit
621.7m TWD
Operating Expenses
-372.6m TWD
Operating Income
249.1m TWD
Other Expenses
-33.1m TWD
Net Income
216m TWD

Margins Comparison
SciVision Biotech Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
TW
SciVision Biotech Inc
TWSE:1786
6.4B TWD
75%
30%
26%
JP
Hoya Corp
TSE:7741
6.8T JPY
86%
28%
24%
CH
Alcon AG
SIX:ALC
38.7B CHF
55%
13%
12%
DK
Coloplast A/S
CSE:COLO B
204B DKK
68%
27%
19%
US
Align Technology Inc
NASDAQ:ALGN
17.2B USD
70%
17%
11%
KR
HLB Inc
KOSDAQ:028300
9.8T KRW
15%
-245%
-358%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51B CNY
72%
45%
42%
CA
Bausch + Lomb Corp
NYSE:BLCO
7B USD
61%
4%
-8%
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.3B USD
65%
32%
29%
UK
ConvaTec Group PLC
LSE:CTEC
4.9B GBP
56%
13%
7%
US
Merit Medical Systems Inc
NASDAQ:MMSI
6B USD
47%
12%
9%
Country TW
Market Cap 6.4B TWD
Gross Margin
75%
Operating Margin
30%
Net Margin
26%
Country JP
Market Cap 6.8T JPY
Gross Margin
86%
Operating Margin
28%
Net Margin
24%
Country CH
Market Cap 38.7B CHF
Gross Margin
55%
Operating Margin
13%
Net Margin
12%
Country DK
Market Cap 204B DKK
Gross Margin
68%
Operating Margin
27%
Net Margin
19%
Country US
Market Cap 17.2B USD
Gross Margin
70%
Operating Margin
17%
Net Margin
11%
Country KR
Market Cap 9.8T KRW
Gross Margin
15%
Operating Margin
-245%
Net Margin
-358%
Country CN
Market Cap 51B CNY
Gross Margin
72%
Operating Margin
45%
Net Margin
42%
Country CA
Market Cap 7B USD
Gross Margin
61%
Operating Margin
4%
Net Margin
-8%
Country US
Market Cap 6.3B USD
Gross Margin
65%
Operating Margin
32%
Net Margin
29%
Country UK
Market Cap 4.9B GBP
Gross Margin
56%
Operating Margin
13%
Net Margin
7%
Country US
Market Cap 6B USD
Gross Margin
47%
Operating Margin
12%
Net Margin
9%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
SciVision Biotech Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
TW
SciVision Biotech Inc
TWSE:1786
6.4B TWD
13%
10%
12%
15%
JP
Hoya Corp
TSE:7741
6.8T JPY
20%
16%
22%
28%
CH
Alcon AG
SIX:ALC
38.7B CHF
6%
4%
5%
5%
DK
Coloplast A/S
CSE:COLO B
204B DKK
29%
11%
21%
13%
US
Align Technology Inc
NASDAQ:ALGN
17.2B USD
11%
7%
16%
9%
KR
HLB Inc
KOSDAQ:028300
9.8T KRW
-33%
-22%
-17%
-17%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51B CNY
25%
23%
27%
36%
CA
Bausch + Lomb Corp
NYSE:BLCO
7B USD
-5%
-3%
2%
2%
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.3B USD
46%
24%
36%
35%
UK
ConvaTec Group PLC
LSE:CTEC
4.9B GBP
9%
4%
9%
7%
US
Merit Medical Systems Inc
NASDAQ:MMSI
6B USD
9%
6%
8%
7%
Country TW
Market Cap 6.4B TWD
ROE
13%
ROA
10%
ROCE
12%
ROIC
15%
Country JP
Market Cap 6.8T JPY
ROE
20%
ROA
16%
ROCE
22%
ROIC
28%
Country CH
Market Cap 38.7B CHF
ROE
6%
ROA
4%
ROCE
5%
ROIC
5%
Country DK
Market Cap 204B DKK
ROE
29%
ROA
11%
ROCE
21%
ROIC
13%
Country US
Market Cap 17.2B USD
ROE
11%
ROA
7%
ROCE
16%
ROIC
9%
Country KR
Market Cap 9.8T KRW
ROE
-33%
ROA
-22%
ROCE
-17%
ROIC
-17%
Country CN
Market Cap 51B CNY
ROE
25%
ROA
23%
ROCE
27%
ROIC
36%
Country CA
Market Cap 7B USD
ROE
-5%
ROA
-3%
ROCE
2%
ROIC
2%
Country US
Market Cap 6.3B USD
ROE
46%
ROA
24%
ROCE
36%
ROIC
35%
Country UK
Market Cap 4.9B GBP
ROE
9%
ROA
4%
ROCE
9%
ROIC
7%
Country US
Market Cap 6B USD
ROE
9%
ROA
6%
ROCE
8%
ROIC
7%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top